How to best define the metabolic syndrome

References

• Eckel R. H., Grundy S. M., Zimmet P. Z. The metabolic syndrome. Lancet 2005; 365: 1415–28
   PubMed Web of Science ®Google Scholar
• Kylin E. Studien über das Hypertonie‐Hyperglyka “mie‐Hyperurika” miesyndrom. Zentralblatt fuer Innere Medizin 1923; 44: 105–27
   Google Scholar
• Vague J., Combes R., Tramoni M., Angeletti S., . Medical complications of obesity., M Mancini, B Lewis, F Contaldo, eds, et al. Academic Press, London 1979, In
   Google Scholar
• Reaven G. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607
   PubMed Web of Science ®Google Scholar
• Matsuda M., Shimomura I., Sata M., Arita Y., Nishida M., Maeda N., et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo‐vascular axis. J Biol Chem 2002; 277: 37487–91
   PubMed Web of Science ®Google Scholar
• Stefan N., Stumvoll M. Adiponectin–its role in metabolism and beyond. Horm Metab Res 2002; 34: 469–74
   PubMed Web of Science ®Google Scholar
• Gil‐Campos M., Canete R. R., Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004; 23: 963–74
   PubMed Web of Science ®Google Scholar
• Alexander H., Balding D., Dobson A., et al. Risk factors and heart disease mortality. A regional perspective. Med J Aust 1986; 144: 20–2
   Google Scholar
• Hanson R. L., Imperatore G., Bennett P. H., Knowler W. C. Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes 2002; 51: 3120–7
   PubMed Web of Science ®Google Scholar
• Cameron A. J., Shaw J. E., Zimmet P. Z. The Metabolic Syndrome: Prevalence in Worldwide Populations. Endocrinology and metabolism clinics of North America. Metabolic Syndrome: Part 1 2004; 33: 351–76
   Google Scholar
• Zimmet P., Boyko E. J., Collier G. R., de Courten M. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players. Ann N Y Acad Sci 1999; 892: 25–44
   PubMed Web of Science ®Google Scholar
• Carr D. B., Utzschneider K. M., Hull R. L., Kodama K., Retzlaff B. M., Brunzell J. D., et al. Intra‐abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53: 2087–94
   PubMed Web of Science ®Google Scholar
• Cheal K. L., Abbasi F., Lamendola C., McLaughlin T., Reaven G. M., Ford E. S. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 2004; 53: 1195–200
   PubMed Web of Science ®Google Scholar
• American College of Endocrinology Task Force on the Insulin Resistance Syndrome. American College of Endocrinology Position Statement on the Insulin Resistance Syndrome. Endocr Pract 2003; 9: 236–52
   Google Scholar
• Aguilar‐Salinas C. A., Rojas R., Gomez‐Perez F. J., Mehta R., Franco A., Olaiz G., et al. The metabolic syndrome: a concept hard to define. Arch Med Res 2005; 36: 223–31
   Web of Science ®Google Scholar
• Wang J. J., Qiao Q., Miettinen M. E., Lappalainen J., Hu G., Tuomilehto J. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care 2004; 27: 2429–37
   PubMedGoogle Scholar
• World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications; Part 1: Diagnosis and Classification of Diabetes Mellitus. Department of Non‐communicable Disease Surveillance, Geneva 1999
   Google Scholar
• Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–97
   PubMed Web of Science ®Google Scholar
• Zimmet P., Alberti G., Shaw J. Mainstreaming the metabolic syndrome: a definitive definition. Med J Aust 2005; 183: 175–6
   PubMed Web of Science ®Google Scholar
• Balkau B., Charles M. A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442–3
   PubMed Web of Science ®Google Scholar
• Liao Y., Kwon S., Shaughnessy S., Wallace P., Hutto A., Jenkins A. J., et al. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care 2004; 27: 978–83
   PubMed Web of Science ®Google Scholar
• Zimmet P., Alberti K. G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782–7
   PubMed Web of Science ®Google Scholar
• Lemieux I., Pascot A., Couillard C., Lamarche B., Tchernof A., Almeras N., et al. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?. Circulation 2000; 102: 179–84
   PubMed Web of Science ®Google Scholar
• Lakka H. M., Laaksonen D. E., Lakka T. A., Niskanen L. K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle‐aged men. JAMA 2002; 288: 2709–16
   PubMed Web of Science ®Google Scholar
• Stern M. P., Williams K., Gonzalez‐Villalpando C., Hunt K. J., Haffner S. M. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?. Diabetes Care 2004; 27: 2676–81
   PubMed Web of Science ®Google Scholar
• Ford E. S. Risks for All‐Cause Mortality, Cardiovascular Disease, and Diabetes Associated With the Metabolic Syndrome: A summary of the evidence. Diabetes Care 2005; 28: 1769–78
   PubMed Web of Science ®Google Scholar
• Tan C. E., Ma S., Wai D., Chew S. K., Tai E. S. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care 2004; 27: 1182–6
   PubMed Web of Science ®Google Scholar
• Lackland D., Orchard T., Keil J. Are race differences in the prevalence of hypertension explained by body mass and fat distribution? A survey in a biracial population. International J Epidemiol 1992; 21: 236–45
   PubMedGoogle Scholar
• Ko G. T., Chan J. C., Cockram C. S., Woo J. Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord 1999; 23: 1136–42
   PubMed Web of Science ®Google Scholar
• Inoue S., Zimmet P., Caterson I., Chunming C., Ikeda Y., Khalid A., et al. The Asia‐Pacific perspective: redefining obesity and its treatment. International Diabetes Institute, Melbourne 2000; 1–56
   Google Scholar
• Genuth S., Alberti K. G., Bennett P., Buse J., Defronzo R., Kahn R., et al. Follow‐up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160–7
   PubMed Web of Science ®Google Scholar